JPRN-UMIN000022900Completed未知
Association of genetic variation of the OPRM1 gene with perioperative opioid analgesia - Association of genetic variation of the OPRM1 gene with perioperative opioid analgesia
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Otaru General Hospital
- Enrollment
- 350
Study Overview
Brief Summary
Sugino S, Hayase T, Higuchi M, Saito K, Moriya H, Kumeta Y, Kurosawa N, Namiki A, Janicki PK: Associations of Mu-opioid receptor gene (OPRM1) gene haplotypes with postoperative nausea and vomiting (PONV) during intravenous patient-controlled analgesia. Exp Brain Res 2014;232:2627-35.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to 85years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with a history of previous PONV, liver deficiency, renal deficiency, dementia, psychiatric diseases, or chronic pain and those who were pregnant
Investigators
Similar Trials
Completed
Not Applicable
OPRM1 A118G SNP, Alcohol Response, and Striatal DopamineAlcoholismNCT00401999National Institute on Alcohol Abuse and Alcoholism (NIAAA)35
Completed
Not Applicable
STUDY OF VARIATION IN OPRM1 Al18G AND ITS CORRELATION WITH DIFFERENCE IN THE INCIDENCE of NAUSEA VOMITING AFTER FEMUR FRACTURE SURGERY IN PATIENTS RECEIVING TRAMADOL FOR PAIN RELIEFCTRI/2021/09/036433niversity College of Medical Sciences and GTB Hospital
Completed
Phase 2
Genetic Effects on Dopamine Response to an OpiatePolymorphism-GeneticPainAddictionNCT01878006National Institute on Alcohol Abuse and Alcoholism (NIAAA)15
Terminated
Not Applicable
Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 MutationAutosomal Dominant Optic AtrophyOptic Atrophy, Autosomal DominantOptic Atrophies, HereditaryKjer Optic AtrophyNCT06140329PYC Therapeutics1
Completed
Phase 1
Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8Gastrointestinal HormonesNCT02507167University Medicine Greifswald19